You are currently viewing a new version of our website. To view the old version click .

Predictive Biomarkers for Colorectal Cancer

Special Issue Information

Dear Colleagues,

An ideal biomarker can help provide optimal treatment by predicting the efficacy and safety of chemotherapeutic treatments, including biologics and immune checkpoint inhibitors. Although many biomarker studies have been reported to date, few validated markers have been identified. In recent years, genetic testing for RAS, BRAF, and MSI has led to the development of individualized treatment for colorectal cancer, and research using new diagnostic techniques is actively being conducted worldwide.

This Special Issue includes RNA and miRNA expression analysis, determination of methylation status, DNA and RNA sequencing, RNA quantification, SNP genotyping, genetic analysis of circulating tumor DNA, and analysis of plasma cytokine levels. Finally, we aim to highlight potential predictive markers for colorectal cancer patients receiving anticancer therapy.

Dr. Mitsukuni Suenaga
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • colorectal cancer
  • biomarker
  • chemotherapy
  • precision medicine
  • genetic analysis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694Creative Common CC BY license